Single-cell immunophenotyping reveals an innate-hyperactive immune continuum observed across autoantibody classes in antisynthetase syndrome that parallels the interferon–complement axis

Antisynthetase syndrome (ASyS) is classified by autoantibodies against aminoacyl-tRNA synthetases, yet patients with identical serology exhibit divergent disease courses. We applied 42-marker mass cytometry to peripheral blood from 10 treatment-exposed ASyS patients (all receiving glucocorticoids at sampling) across four autoantibody classes (anti-Jo-1, anti-PL-12, anti-EJ, and anti-PL-7) and asked whether patient-level immunological structure would follow serology, be robust to small-cohort instability, and reconstruct the muscle interferon-complement axis. Patients were ordered along the first principal component of a 66-dimensional per-patient feature vector—an unsupervised innate-hyperactive axis—with bootstrap and leave-one-out stability testing. A 41-gene signature of the innate-hyperactive end of the axis, derived independently of the validation cohorts, was projected onto three muscle-biopsy cohorts (n = 165, 77, and 59) and an adult whole-blood cohort containing healthy controls (n = 24). Patients occupied a continuum rather than discrete groups. The axis (35.8% of variance) showed no detectable association with autoantibody class (Kruskal–Wallis P = 0.90; class explained 12% of axis variance, 95% CI 0–31%), and the three anti-Jo-1 patients spanned 91% of its range; with two or three patients per class, this is compatible with, but does not establish, independence from serology. Rank order was stable under bootstrap (mean rank SD 1.23 positions versus 2.87 expected by chance). Three descriptive regions—IT1 innate-hyperactive, IT2 CD4-memory-expanded, and IT3 lymphoid-quiescent—were delimited along the axis. The IT1 signature separated inflammatory myopathies from normal muscle in all three muscle cohorts (pooled Cohen’s d ranging 1.58–2.24 across combined disease groups, with an ASyS-specific estimate of 2.50 derived from a single cohort and not a pooled estimate). Although it contains no complement genes, ASyS biopsies scoring high for it were enriched for complement-cascade genes, reconstructing the interferon-complement axis. In whole blood, its type-I ISG-core arm, but not its composite score, separated myositis and anti-Jo-1-positive patients from healthy controls (d 1.31 and 2.16; AUC 0.88 and 0.96). In this small, treatment-exposed cohort, peripheral-blood immunophenotyping resolves a continuous axis of immune variation that cuts across autoantibody classes and complements serology.
Take Your Experience to the Next Level
NewDownload our mobile app for a faster and better experience.
Comments
0U
Join the discussion
Sign in to leave a comment